Flo-Pred

Product NDC: 51672-1338
11-digit product format: 516721338
Labeler code: 51672
Product ID: 51672-1338_79fbfd7c-6b29-466c-8e65-015be1652aea
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Prednisolone Acetate
Dosage form: SUSPENSION
Route: ORAL
Labeler: Taro Pharmaceuticals U.S.A., Inc.
Application: NDA022067
Marketing category: NDA
Marketing start: 2008-01-17
Marketing end: 0000-00-00
Substance: PREDNISOLONE ACETATE
Active strength: 17 mg/5mL
Pharmacologic classes: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	51672-1338		D	Discontinued by firm	2026-08-11
excluded package	package	51672-1338	51672-1338-3	D	Discontinued by firm	2026-08-11
excluded package	package	51672-1338	51672-1338-5	D	Discontinued by firm	2026-08-11
excluded package	package	51672-1338	51672-1338-6	D	Discontinued by firm	2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51672-1338-3	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51672-1338-6	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51672-1338-5	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51672-1338-3	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51672-1338-6	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51672-1338-5	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51672-1338-3	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51672-1338-6	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51672-1338-5	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51672-1338-3	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51672-1338-6	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51672-1338-5	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51672-1338-3	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51672-1338-6	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51672-1338-5	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51672-1338-3	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51672-1338-6	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51672-1338-5	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51672-1338-3	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51672-1338-6	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51672-1338-5	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51672-1338-3	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51672-1338-6	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51672-1338-5	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51672-1338-3	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51672-1338-6	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51672-1338-5	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	51672-1338-3	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	51672-1338-6	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	51672-1338-5	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	51672-1338-3	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	51672-1338-6	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	51672-1338-5	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	51672-1338-3	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	51672-1338-6	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	51672-1338-5	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022067-001	FLO-PRED	PREDNISOLONE ACETATE	EQ 5MG BASE/5ML	SUSPENSION / ORAL			2008-01-17
N022067-002	FLO-PRED	PREDNISOLONE ACETATE	EQ 15MG BASE/5ML	SUSPENSION / ORAL			2008-01-17

Orange Book patents#

Current patent rows page 1 of 1 · 4 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N022067-001	7799331	2028-10-11	U-1068	Drug product	2012-04-16
N022067-001	7799331	2028-10-11	U-139	Drug product	2012-04-16
N022067-002	7799331	2028-10-11	U-1068	Drug product
N022067-002	7799331	2028-10-11	U-139	Drug product

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022067-001	FLO-PRED	EQ 5MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N022067-002	FLO-PRED	EQ 15MG BASE/5ML	SUSPENSION / ORAL	2008-01-17	`782e0a99824c…`

Observed Orange Book patent history#

Patent history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N022067-001	7799331	2028-10-11	U-1068	Drug product	2012-04-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022067-001	7799331	2028-10-11	U-139	Drug product	2012-04-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022067-002	7799331	2028-10-11	U-139	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022067-002	7799331	2028-10-11	U-1068	Drug product		`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022067-001	7799331	2028-10-11	U-1068	Drug product	2012-04-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022067-001	7799331	2028-10-11	U-139	Drug product	2012-04-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022067-002	7799331	2028-10-11	U-139	Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022067-002	7799331	2028-10-11	U-1068	Drug product		`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022067-001	7799331	2028-10-11	U-1068	Drug product	2012-04-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022067-001	7799331	2028-10-11	U-139	Drug product	2012-04-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022067-002	7799331	2028-10-11	U-139	Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022067-002	7799331	2028-10-11	U-1068	Drug product		`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022067-001	7799331	2028-10-11	U-1068	Drug product	2012-04-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022067-001	7799331	2028-10-11	U-139	Drug product	2012-04-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022067-002	7799331	2028-10-11	U-139	Drug product		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022067-002	7799331	2028-10-11	U-1068	Drug product		`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022067-001	7799331	2028-10-11	U-1068	Drug product	2012-04-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022067-001	7799331	2028-10-11	U-139	Drug product	2012-04-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022067-002	7799331	2028-10-11	U-139	Drug product		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022067-002	7799331	2028-10-11	U-1068	Drug product		`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022067-001	7799331	2028-10-11	U-1068	Drug product	2012-04-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022067-001	7799331	2028-10-11	U-139	Drug product	2012-04-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022067-002	7799331	2028-10-11	U-139	Drug product		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022067-002	7799331	2028-10-11	U-1068	Drug product		`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022067-001	7799331	2028-10-11	U-1068	Drug product	2012-04-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022067-001	7799331	2028-10-11	U-139	Drug product	2012-04-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022067-002	7799331	2028-10-11	U-139	Drug product		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022067-002	7799331	2028-10-11	U-1068	Drug product		`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022067-001	7799331	2028-10-11	U-1068	Drug product	2012-04-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022067-001	7799331	2028-10-11	U-139	Drug product	2012-04-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022067-002	7799331	2028-10-11	U-139	Drug product		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022067-002	7799331	2028-10-11	U-1068	Drug product		`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022067-001	7799331	2028-10-11	U-1068	Drug product	2012-04-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022067-001	7799331	2028-10-11	U-139	Drug product	2012-04-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022067-002	7799331	2028-10-11	U-139	Drug product		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022067-002	7799331	2028-10-11	U-1068	Drug product		`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022067-001	7799331	2028-10-11	U-1068	Drug product	2012-04-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022067-001	7799331	2028-10-11	U-139	Drug product	2012-04-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022067-002	7799331	2028-10-11	U-139	Drug product		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022067-002	7799331	2028-10-11	U-1068	Drug product		`d06236e962d9…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51672-1338-3	ML - Milliliter	51672-1338	617790f0-bac6-477b-a58d-aa54eb0e0113	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Prednisolone Acetate	ACTIVE INGREDIENT	8B2807733D	FLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]	6
prednisolone	ACTIVE MOIETY	9PHQ9Y1OLM	FLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]	6
Butylparaben	INACTIVE INGREDIENT	3QPI1U3FV8	FLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]	6
Carbomer Homopolymer Type B	INACTIVE INGREDIENT	HHT01ZNK31	FLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]	6
Edetate Disodium	INACTIVE INGREDIENT	7FLD91C86K	FLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]	6
Glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	FLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]	6
Poloxamer 188	INACTIVE INGREDIENT	LQA7B6G8JG	FLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]	6
propylene glycol	INACTIVE INGREDIENT	6DC9Q167V3	FLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]	6
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	FLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]	6
sucralose	INACTIVE INGREDIENT	96K6UQ3ZD4	FLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]	6
water	INACTIVE INGREDIENT	059QF0KO0R	FLO-PRED (PREDNISOLONE ACETATE) SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.]	6

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
8B2807733D	PREDNISOLONE ACETATE	52-21-1	PREDNISOLONE ACETATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
51672-1338-3	51672133803	1 BOTTLE in 1 CARTON (51672-1338-3) > 52 mL in 1 BOTTLE	1 bottle	2008-01-17	0000-00-00	No	No	Current
51672-1338-5	51672133805	1 BOTTLE in 1 CARTON (51672-1338-5) > 37 mL in 1 BOTTLE	1 bottle	2008-01-17	0000-00-00	No	No	Current
51672-1338-6	51672133806	1 BOTTLE in 1 CARTON (51672-1338-6) > 65 mL in 1 BOTTLE	1 bottle	2008-01-17	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Flo-Pred	Taro Pharmaceuticals U.S.A., Inc. \| Taro Pharmaceuticals Inc.	2019-02-28	HUMAN PRESCRIPTION DRUG LABEL	8